122 related articles for article (PubMed ID: 3182416)
1. The in-vitro activity of PD127,391, a new quinolone.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1988 Aug; 22(2):135-41. PubMed ID: 3182416
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
Rolston KV; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1990; 36(5):365-72. PubMed ID: 2209169
[TBL] [Abstract][Full Text] [Related]
4. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D
J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.
Smith RP; Baltch AL; Hammer MC; Conroy JV
Antimicrob Agents Chemother; 1988 Sep; 32(9):1450-5. PubMed ID: 3196008
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Chin NX; Neu HC
J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
[TBL] [Abstract][Full Text] [Related]
9. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of four new fluoroquinolones.
García-Rodríguez JA; García Sánchez JE; García García MI; Fresnadillo MJ; Trujillano I; García Sánchez E
J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
King A; Shannon K; Slegg J; Phillips I
J Antimicrob Chemother; 1986 Aug; 18(2):163-9. PubMed ID: 3463557
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
King A; Shannon K; Phillips I
J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Ashby JP; Matthews RS; Wise R
J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
Rolston KV; LeBlanc B; Ho DH; Bodey GP
J Antimicrob Chemother; 1990 Jul; 26(1):39-44. PubMed ID: 2211445
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
Huband MD; Cohen MA; Meservey MA; Roland GE; Yoder SL; Dazer ME; Domagala JM
Antimicrob Agents Chemother; 1993 Dec; 37(12):2563-70. PubMed ID: 8109918
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.
Fung-Tomc JC; Minassian B; Kolek B; Huczko E; Aleksunes L; Stickle T; Washo T; Gradelski E; Valera L; Bonner DP
Antimicrob Agents Chemother; 2000 Dec; 44(12):3351-6. PubMed ID: 11083639
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
Sun ZM; Maskell JP; Sehgal SC; Williams JD
Infection; 1989; 17(3):165-7. PubMed ID: 2737760
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
